In last trading session, CryoPort Inc (NASDAQ:CYRX) saw 1.15 million shares changing hands with its beta currently measuring 1.74. Company’s recent per share price level of $7.04 trading at $0.39 or 5.86% at ring of the bell on the day assigns it a market valuation of $351.36M. That closing price of CYRX’s stock is at a discount of -185.51% from its 52-week high price of $20.10 and is indicating a premium of 34.94% from its 52-week low price of $4.58. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.84 million shares which gives us an average trading volume of 340.00K if we extend that period to 3-months.
For CryoPort Inc (CYRX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.24 in the current quarter.
CryoPort Inc (NASDAQ:CYRX) trade information
Upright in the green during last session for gaining 5.86%, in the last five days CYRX remained trading in the green while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $7.04 price level, adding 1.26% to its value on the day. CryoPort Inc’s shares saw a change of -9.51% in year-to-date performance and have moved 6.51% in past 5-day. CryoPort Inc (NASDAQ:CYRX) showed a performance of 3.23% in past 30-days. Number of shares sold short was 2.05 million shares which calculate 8.56 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 11 to the stock, which implies a rise of 36.0% to its current value. Analysts have been projecting 11 as a low price target for the stock while placing it at a high target of 11. It follows that stock’s current price would drop -56.25% in reaching the projected high whereas dropping to the targeted low would mean a loss of -56.25% for stock’s current value.
CryoPort Inc (CYRX) estimates and forecasts
This year revenue growth is estimated to rise 6.96% from the last financial year’s standing.
7 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 57.97M for the same. And 7 analysts are in estimates of company making revenue of 60.76M in the next quarter. Company posted 54.59M and 57.6M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -35.29% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 54.79% while estimates for its earnings growth in next 5 years are of 31.37%.
CryoPort Inc (NASDAQ:CYRX)’s Major holders
Insiders are in possession of 2.67% of company’s total shares while institution are holding 101.09 percent of that, with stock having share float percentage of 103.85%. Investors also watch the number of corporate investors in a company very closely, which is 101.09% institutions for CryoPort Inc that are currently holding shares of the company. BROWN CAPITAL MANAGEMENT LLC is the top institutional holder at CYRX for having 6.19 million shares of worth $42.75 million. And as of 2024-06-30, it was holding 12.5378 of the company’s outstanding shares.
The second largest institutional holder is MORGAN STANLEY, which was holding about 4.69 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.5133 of outstanding shares, having a total worth of $32.44 million.
On the other hand, Alger Small Cap Focus Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024 , the former fund manager was holding 1.94 shares of worth $13.68 million or 3.89% of the total outstanding shares. The later fund manager was in possession of 1.47 shares on Dec 31, 2024 , making its stake of worth around $10.38 million in the company or a holder of 2.95% of company’s stock.
